Company Black Diamond Therapeutics, Inc. OTC Markets
Equities
BDTX
US09203E1055
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.785 USD | 0.00% | 0.00% | 0.00% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Elizabeth Buck
FOU | Founder | 49 | 01/14/01 |
Mark Velleca
CEO | Chief Executive Officer | 60 | 09/21/09 |
David Epstein
FOU | Founder | 65 | 01/14/01 |
Fang Ni
DFI | Director of Finance/CFO | 37 | 04/20/04 |
Sergey Yurasov
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/22/01 |
Chief Operating Officer | 59 | 29/19/29 | |
Julie Seidel
IRC | Investor Relations Contact | - | - |
Melanie Morrison
PRN | Corporate Officer/Principal | - | 01/22/01 |
Human Resources Officer | 52 | 22/22/22 | |
Erika Jones
AUD | Comptroller/Controller/Auditor | 39 | 01/19/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Epstein
FOU | Founder | 65 | 01/14/01 |
Mark Velleca
CEO | Chief Executive Officer | 60 | 09/21/09 |
Ali Behbahani
BRD | Director/Board Member | 48 | 01/18/01 |
Garry Menzel
BRD | Director/Board Member | 59 | 01/14/01 |
Kapil Dhingra
BRD | Director/Board Member | 64 | 19/21/19 |
Samarth Kulkarni
BRD | Director/Board Member | 45 | 01/19/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 56,252,794 | 54,935,052 ( 97.66 %) | 0 | 97.66 % |
Company contact information
Black Diamond Therapeutics, Inc.
One Main Street 14th floor
02142, Cambridge
+
http://www.blackdiamondtherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.08% | 12TCr | |
+13.02% | 11TCr | |
-9.48% | 2.39TCr | |
-1.69% | 2.16TCr | |
-10.60% | 1.9TCr | |
-41.25% | 1.7TCr | |
-14.34% | 1.63TCr | |
+6.53% | 1.41TCr | |
+30.66% | 1.2TCr |
- Stock Market
- Equities
- BDTX Stock
- BDTX Stock
- Company Black Diamond Therapeutics, Inc.